Medical Staff Portal
News, Alerts & Events

fluVOXamine 50 and 100 mg tablets

December 27 , 2017

The Issue:

There is a back order of fluVOXamine 50 and 100 mg tablets. All Canadian manufacturers are experiencing a supply disruption. The earliest estimated release date is for Luvox® brand 50 and 100 mg tablets in early January 2018.

Stock levels are low and may not meet current demands. Inventory might be depleted prior to the resolution of this back order.

Key changes include:

•Physicians should be aware of the shortage of fluVOXamine 50 and 100 mg tablets

•Conserve fluVOXamine tablets for use in patients for whom alternatives are not suitable.

•Use a therapeutic alternative* as clinically appropriate. Potential alternatives include the following selective serotonin-reuptake inhibitors (SSRI):

    • Citalopram
    • Escitalopram
    • Fluoxetine
    • Paroxetine
    • Sertraline

*Alternatives are provided for clinician information and may not be appropriate for all clinical situations. The information provided does not replace clinician judgement.


Please post this notice in your area and ensure all staff is informed about the change.


Please contact your site pharmacy department with any questions or concerns.

Download PDF